Press release - COVID-19 vaccines: MEPs seek answers from industry representatives

MEPs highlighted the challenge of ensuring that vaccines are available as soon as possible, while at the same time building public trust in vaccination.

Metadata

Provider:

URL:

https://www.europarl.europa.eu/news/en/press-room/20200918IPR87419/

Retrieved on:

Wednesday, September 23, 2020

Information

Tags:

Articles, Companies, Health, CureVac, Tübingen, Sanofi, Vaccine, Vaccination, Transparency

Summary

Key Points:

MEPs highlighted the challenge of ensuring that vaccines are available as soon as possible, while at the same time building public trust in vaccination.
We wanted to have more information on the state of research, the commitments made by laboratories, and whether they will be able to meet them.
The lack of transparency surrounding these contracts was very clearly highlighted during this hearing where Parliament played a role in ensuring democratic accountability, he added.
During the debate, industry representatives from Sanofi and Curevac reiterated their commitments to produce one billion doses in 2021, and the importance of keeping safety first.